+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 15Years - 30Years
All Genders
Healthy Volunteers
ID06250504

Evaluating Long-Acting and Oral HIV Prevention Choices Integrated with Community Sexual and Reproductive Health Services in Rural South Africa for Ages 15 to 30

Led by Africa Health Research Institute · Updated on 2026-07-09

2052

Participants Needed

1

Research Sites

22 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effectiveness and real-world use of offering a choice of HIV Pre-Exposure Prophylaxis PrEP options through community-based sexual and reproductive health SRH services for adolescents and young adults aged 15 to 30 living in rural South Africa. This trial compares adding long-acting PrEP options like injectable cabotegravir CAB LA and dapivirine vaginal ring, along with post-exposure prophylaxis PEP, to the current standard daily oral PrEP in community settings. The study aims to improve PrEP uptake, retention, and reduce sexually transmissible HIV in this population. Participants in intervention clusters are offered a choice between daily oral tenofoviremtricitabine, injectable CAB LA given every two months, dapivirine vaginal rings changed every three months, or PEP packs. The control clusters receive the standard oral PrEP with integrated community SRH services. Follow-up includes HIV and pregnancy testing, STI management, and peer navigator support to promote adherence. Safety monitoring involves blood tests for liver and kidney function, with visits spaced from monthly to every few months depending on the PrEP method. During the study, participants will have regular assessments including HIV testing every two months, pregnancy testing, STI screening, and blood tests annually. Peer navigators provide psychosocial support and reminders for follow-up visits. Researchers will track PrEP uptake, retention, adherence, HIV incidence, and safety outcomes over 14 months. The study also explores the acceptability, feasibility, and cost-effectiveness of delivering these PrEP options through community-based services. Total study duration extends up to 20 months for some outcome measures.

CONDITIONS

Brief Title

Long-Acting HIV Pre-Exposure Prophylaxis Integrated With Sexual and Reproductive Health - cRCT

Research Team

M

Maryam G Shahmanesh, MBBChir PhD

L

Limakatso Lebina, MBBS PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here